Peter Dewland Consulting

image

Peter Dewland - Independent Consultant in Pharmaceutical Medicine.

A Master’s degree in Medical Ethics together with degrees in Biochemistry and Medicine along with 30 years experience of developing new drugs makes me an obvious choice to help you with your drug development project. A founder member of the Faculty of Pharmaceutical Medicine I now both teach and examine students of this specialty.

Short Resumé

image

Having qualified in Biochemistry and Medicine at St Thomas’s Hospital, London I embarked upon a series of posts aimed at training me for General Medical Practice. These included Medicine, Surgery, Accident and Emergency, Orthopaedics, Obstetrics and Gynaecology and Paediatrics. After a short spell of 4 years as a GP I was tempted to move into the then embryonic CRO industry. I continued my training gaining a Masters in Medical Ethics and a Diploma in Clinical Pharmacology. I became a founder member of the Faculty of Pharmaceutical Medicine at the Royal College of Physicians and I am now involved in both training and examining students there for their various post graduate qualifications.

I concentrated on early phase research and helped grow the UK’s oldest Phase I unit to become a successful and thriving business. During this era I worked in most therapeutic areas and developed many PD markers and human disease models. I developed an interest in Research Ethics and started the first national training course for members of Ethics Committees which is still running to this day. In 1997 I felt the need to experience later phase research so joined a large global CRO and gained experience in Phases II and III in several therapeutic areas. In that post I started and built up a successful, international Medical Affairs Department and also took over the company’s dealings with Japan. In that role I developed business from nothing to $40million a year.

I eventually ended up running the UK office and dealing with all the personnel issues as well as having to supervise Safety, Regulatory and Writing departments. Finally the lure of Wales was too great and I returned to my original CRO to take control of the Phase I unit again. By now there were far more studies being done in patient groups and I helped grow this part of the business eventually being one of the first two UK units to gain MHRA accreditation for EAG (high risk) molecules. Having recently retired from that role I am now an independent Consultant in Pharmaceutical Medicine with my expertise spanning the whole field whilst my main interest remains in early phase studies. I enjoy teaching both physicians and scientists on a variety of courses associated with pharmaceutical development. I have recently been responsible for setting up and gaining MHRA accreditation for a new hospital based, purpose built Clinical Pharmacology unit at one of the UK's major teaching hospitals.